M9241
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M9241, covering 2022-05-18 to 2022-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer [Phase 1, Phase 2]